Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -263.42% | $ -38.73M | $ 14.7M |
3/31/2025 | -772.39% | $ -55.45M | $ 7.18M |
12/31/2024 | -871.25% | $ -65.92M | $ 7.57M |
9/30/2024 | -843.05% | $ -77.64M | $ 9.21M |
6/30/2024 | -581.38% | $ -80.86M | $ 13.91M |
3/31/2024 | -866.91% | $ -77.27M | $ 8.91M |
12/31/2023 | -1283.35% | $ -65.76M | $ 5.12M |
9/30/2023 | -1524.13% | $ -48.83M | $ 3.2M |
6/30/2023 | -272.69% | $ -23.47M | $ 8.61M |
3/31/2023 | -242.8% | $ -20.97M | $ 8.64M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for VERRICA PHARMACEUTICALS INC is calculated as follows: Op. Inc. [ $ -36.14M ] / Revenues [ $ 0 ]
(=) Operating % [ 0% ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |